Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Cytecare Announces the Appointment of Dr. Roopesh N as Consultant and Surgeon - Gynecologic Oncology - The Pharma Times | Pharma & Health Care News Portal
Categories: Appointment

Cytecare Announces the Appointment of Dr. Roopesh N as Consultant and Surgeon – Gynecologic Oncology

Bengaluru, June 03, 2017: Bengaluru-based Cytecare cancer hospitals today announced the appointment of Dr. Roopesh N as consultant and surgeon – gynaecologic oncology. With over 10 years of experience in the field, Dr. Roopesh is a specialist in cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancers, fertility sparing surgeries for gynaecologic malignancies, surgery for endometrial cancers – open and laparoscopic intraperitoneal chemotherapy for ovarian cancers, nerve-sparing radical hysterectomy for cervical cancers and radical vulvectomies. Additionally, he also specialises in clinical care. He also serves as a lecturer and research consultant. Being an organ specific oncologist, Dr. Roopesh’s expert diagnosis will go a long way in reducing the number of follow-ups a patient has to currently undergo. His appointment bears further testament to Cytecare’s mission to be a leader in organ specific cancer diagnosis and treatment.

Dr. Roopesh is a surgical expert and has successfully conducted major gynaecological and onco-surgeries. His primary area of expertise are laparoscopic intraperitoneal chemotherapy for ovarian cancers, advanced ovarian cancers fertility sparing surgeries, gynaecologic malignancies surgery for endometrial cancers. Dr. Roopesh with his remarkable training approach is successfully skilled from prestigious oncology institutes including Tata Memorial Hospital, Mumbai, Amrita Institute of Medical Sciences and Research Centre Kerala, Basavatarakam Indo-American Cancer Hospital & Research Centre, Hyderabad, MIE University Hospital, Japan, etc.

Commenting on the appointment, Mr. Suresh Ramu, CEO & Co-founder, Cytecare Hospitals, said “We are pleased to have an oncologist of Dr. Roopesh’s calibre join us at Cytecare because we understand the importance of an organ specific specialist. He will play a crucial role at the hospital, as under his guidance, we are positive that cases will be better treated than a generalist. Dr. Roopesh comes with over a decade of clinical practice and immense knowledge in the gynaecologic oncology space and surgical expertise that will be an asset for the team here. Being an organ centric cancer care hospital, we aim to have the best oncologists on board who can add value to specialised cancer treatment.”

Prior to joining Cytecare, Dr. Roopesh has practiced gynaecology oncology in various premier hospitals like HCG hospitals, Bangalore, JSS hospital & medical college, Mysore, Bangalore Baptist hospital and Sri Siddhartha medical college.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

3 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

5 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago